Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atomoxetine modulation of learning noise in value-based decision making
NL-OMON51201Active, not recruiting
- Sponsor
- Leiden University
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial comparing Atomoxetine condition with Placebo condition (2 arms). Primary endpoints: Choice history, Outcome history and 8 more. Started May 2021; status: active, not recruiting.
02
Drugs
atomoxetine
Beyond the preview
Go deeper on NL-OMON51201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON51201.